Effects of Antenatal Exercises on Clinical Outcomes in Pregnant Females With Gestational Diabetes Mellitus

NCT ID: NCT04859348

Last Updated: 2021-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-01

Study Completion Date

2021-04-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gestational diabetes mellitus (GDM) GDM is the most common complication that affects the health of the child and mother during pregnancy. Objectives was to determine the effects of Antenatal exercises on glucose levels, mode of delivery and APGAR Score in females with gestational diabetes mellitus.

This Randomized controlled trial study was conducted on N= 72 pregnant females at department of Gynecology and Obstetrics, Mian Munshi DHQ Hospital, Lahore after Ethical approval of synopsis from institutional Review Board of the University of Lahore . The data was entered and analyzed using SPSS Version 24. .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gestational diabetes mellitus (GDM) is defined as glucose intolerance resulting in hyperglycemia of variable severity with onset during pregnancy. During pregnancy, GDM is the most common complication occurs and it affects the health of the child and mother.

This study aim was to investigate the effect of antenatal exercise on clinical outcomes in pregnant females with gestational diabetes mellitus.

Study Design: Randomized controlled trial. Settings: It was conducted at department of Gynecology and Obstetrics, Mian Munshi DHQ Hospital, Lahore.

Sample Size:

The calculated sample size is 30 in each group using APGAR scale as outcome measure. After adding 20% drop out the sample size will become 30+6 = 36 in each group.

Sampling Technique: Purposive sampling technique

Outcome measuring Tools -

• APGAR scale DATA COLLECTION PROCEDURE

All the participants visited from the gynecology department after the diagnosis of GDM was considered after the initial screening test. Following the inclusion and exclusion criteria before adding them to the study. These patients were allotted in two groups i.e. group A and group B via the lottery method. Informed consent were taken in written form showing that they are willing to participate in the study. The therapist had assessed the patients before the start of rehabilitation program:

Group A includes participants received the routine physical therapy only. Group B includes participants were given exercise program from 20- 24 weeks of gestation to till the date of delivery, with addition of the routine physical therapy plan.

Group A: Routine Physical Therapy (RPT) + Insulin therapy Group A- (n=36) participants received only routine treatment for gestational diabetes mellitus which includes insulin therapy and diet control programs guided by a gynecologist and routine physical therapy which includes walk for 1 hr which includes proper warm up and cool down periods, three times in a week from 20-24 weeks of gestation to till delivery.

Group -B-Antenatal + RPT + Insulin therapy+ Exercise Group B- (n=36) participants completed routine therapy and antenatal exercises which includes Aerobic and strengthening Exercises with workout 3 days a week, for 2 weeks (6 sessions under the supervision of physiotherapist and remaining was performed at home along with routine treatment for gestational diabetes mellitus which includes insulin therapy and diet control program as guided by gynecologist. The exercise program was started with quarter-hour moderate-intensity aerobic activity and slowly rising the duration to a maximum of half-hour each exercise session. A 10-15-minute warm-up physical exercise, and a 10-15-minute cool-down period was included. The duration of the exercise was assessed by using target pulse rate, the Borg scale (rate of perceived exertion), or the 'talk test.' American College of Obstetricians and Gynecologists Guideline corresponded to exercise of moderate-intensity were followed. Aerobic exercise includes a brisk walk to train the main muscle groups which includes, chest muscles, deltoid, quadriceps, and calf muscles were targeted the main muscle groups .In sitting position, strengthening exercise were performed in which one end of the Thera band was placed under the foot, hold for 5 seconds then released along with 10 repetitions. The movements were involvement of wall push-ups, shoulder flexion, shoulder abduction, knee extension and ankle plantar flexion. It was guided that pregnant women avoid exercise promptly if they experience any signs such as dizziness, dyspnea, amniotic fluid leaking or vaginal bleeding. Besides, group participant will wear loose-fitting clothing and keep hydrated while exercising in an environment with adequate temperature and moisture. All sessions of the exercise under supervision were fully documented on successful completion.

Confidentiality of all the details were ensured. A blind study (to remove chance of bias), in which random allocation of women between two categories, via the lottery system was executed.

Follow Ups Total 3 sessions per week were given to the patients for 60 min., from 20- 24 weeks of gestation to till the time of delivery. Home plan was given to the participants and follow up was done whenever participants came to gynecology department.

PROFORMA/QUESTIONNAIRE

Title "Effects of Antenatal exercises on clinical outcomes in pregnant females with gestational diabetes mellitus: A Randomized Controlled Trial" Name………………... Age …………………. Height ………………. Weight ………………… Phone no …………………. Gestation age …………… Borg scale ……………. BMI ………………. Evaluation Sheet

Group A (RPT+ Insulin therapy)

Outcome variables:

1. Glucose level ………….
2. Delivery:

i) Normal delivery ii) C-Section
3. APGAR Score:

i) 1st min ……………. ii) 5th min …………….
4. Gestational age at birth ………

Outcome variables:

GROUP B (RPT+ Antenatal exercises+ Insulin therapy)

1. Glucose level ………….
2. Delivery:

i) Normal delivery ii) C-Section
3. APGAR Score:

i) 1st min ……………. ii) 5th min ……………. iii)
4. Gestational age at birth………

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

G- A 36 participants received only routine treatment for GDM G- B 36 participants receive routine therapy (insulin therapy and diet control) and Aerobic and strengthening Exercises.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
outcomes accessor donot know the type of intervention given to patient not during evaluation or data record

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group-A ( RPT+ Insulin Therapy)

Group A includes participants received the routine physical therapy only.

Group Type EXPERIMENTAL

routine physical therapy

Intervention Type OTHER

G- A 36 participants received only routine treatment for GDM which includes insulin therapy and diet control guided by gynecologist and routine physical therapy which includes walk for 1 hr with proper warm up and cool down periods, three times in a week from 20-24 weeks of gestation to till delivery.

Group-B (RPT+ Antenatal Exercises+ Insulin therapy)

Group B includes participants were given antenatal exercise program from 20- 24 weeks of gestation to till the date of delivery, with addition of the routine physical therapy plan.

Group Type EXPERIMENTAL

routine physical therapy and antenatal exercises

Intervention Type OTHER

G- B 36 participants receive routine therapy (insulin therapy and diet control) and Aerobic and strengthening Exercises for 3 days a week, for 2 weeks 6 sessions under the supervision of physiotherapist and remaining was performed at home. Exercise was started from 15 min and reach to 30 mins gradually.10-15-minute warm-up, cool-down period was included by using ACOG Guideline. Aerobic exercise includes a brisk walk and strengthening exercise were performed with hold for 5 seconds and 10 repetitions. Exercise should stop if they experience any signs of dizziness, dyspnea, amniotic fluid leaking or vaginal bleeding. Confidentiality and blindness ensure by random allocation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

routine physical therapy

G- A 36 participants received only routine treatment for GDM which includes insulin therapy and diet control guided by gynecologist and routine physical therapy which includes walk for 1 hr with proper warm up and cool down periods, three times in a week from 20-24 weeks of gestation to till delivery.

Intervention Type OTHER

routine physical therapy and antenatal exercises

G- B 36 participants receive routine therapy (insulin therapy and diet control) and Aerobic and strengthening Exercises for 3 days a week, for 2 weeks 6 sessions under the supervision of physiotherapist and remaining was performed at home. Exercise was started from 15 min and reach to 30 mins gradually.10-15-minute warm-up, cool-down period was included by using ACOG Guideline. Aerobic exercise includes a brisk walk and strengthening exercise were performed with hold for 5 seconds and 10 repetitions. Exercise should stop if they experience any signs of dizziness, dyspnea, amniotic fluid leaking or vaginal bleeding. Confidentiality and blindness ensure by random allocation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Panel patients who are covered under medical facility provided by the company
* Booked cases
* Participant's Borg scale score 6 to 14
* Age 20-35 years
* 20-24 weeks of gestation
* Diagnosed case of GDM
* Primigravida
* BMI does not exceed 40 kg/m²

Exclusion Criteria

* Females diagnosed with vascular complications (Preeclampsia, hemolysis etc.)
* Uncontrolled diabetes mellitus
* Autonomic dysfunction /Peripheral neuropathy (Damage to the nerves outside of the brain and spinal cord which effect sensations)
* Nephropathy or retinopathy (Damage to the small blood vessels of kidneys and eyes)
* Twins fetus
* Placenta Previa (placenta partially or totally covers the mother's cervix)
* Fetal anomalies
* Female choice for caesarean section
* Intrauterine growth retardation (fetal complication)
* Short cervix length
* Antepartum hemorrhage (bleeding from the genital tract)
Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lahore

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anum Sattar, MPhil

Role: PRINCIPAL_INVESTIGATOR

student

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

[email protected]

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-UOL-FAHS/600-1/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.